| Study | Exclusion reasons | Remarks | Reference(s) | ||
|---|---|---|---|---|---|
| CurrentS, 2016 | randomized controlled trial |
Reck M Lung Cancer 2016; 99:94-101-. 10.1016/j.lungcan.2016.06.019 |
|||
| EMPHASIS-lung, 2017 | randomized controlled trial | The final analysis of EMPHASIS-lung did not show a differential effect on PFS for erlotinib versus docetaxel |
Smit EF J Thorac Oncol 2017; 12:752-762-. 10.1016/j.jtho.2016.12.017 |
||
| NCCCTS-07-255, 2017 | randomized controlled trial |
Lee JS Cancer Res Treat 2017; 49:981-989-. 10.4143/crt.2016.522 |
-
About us
-
Contact us
-
Method
-
RSS
Made with
in Lyon
-
Credits
-
Privacy policy
-
